Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 3, 2010, Pages 321-326

  Koletzko, Berthold ^a   Goulet, Olivier ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cholestatic liver disease; Intestinal failure associated liver disease; Intravenous lipid emulsion; Marine oil; Omega 3 fatty acids

Indexed keywords

ALPHA TOCOPHEROL; BETA TOCOPHEROL; BILIRUBIN; CAMPESTEROL; COCONUT OIL; DELTA TOCOPHEROL; FISH OIL; GAMMA TOCOPHEROL; ICOSAPENTAENOIC ACID; LIPID EMULSION; OLIVE OIL; OMEGA 6 FATTY ACID; SITOSTEROL; SOYBEAN OIL; STIGMASTEROL;

ANTIOXIDANT ACTIVITY; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; HUMAN; INFECTION PREVENTION; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION; NONHUMAN; OXIDATIVE STRESS; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS; REVIEW; SHORT BOWEL SYNDROME; CHEMISTRY; CHILD; CHOLESTASIS, INTRAHEPATIC; INFANT; INTESTINAL DISEASES;

CHILD; CHOLESTASIS, INTRAHEPATIC; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; INFANT; INTESTINAL DISEASES; PARENTERAL NUTRITION;

EID: 77951482107     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283385407     Document Type: Review

References (42)

1. Koletzko B, Goulet O, Hunt J, et al. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41 (Suppl 2):S1-S87.
2. Fusch C, Bauer K, Bohles HJ, et al. Neonatology/paediatrics: guidelines on parenteral nutrition, chapter 13. Ger Med Sci 2009; 7:Doc15.
3. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998; 27:131-137. (Pubitemid 28354942)
4. Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 2009; 14:256-261.
5. Willis TC, Carter BA, Rogers SP, et al. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2010; 34:32-37.
6. Robinson DT, Ehrenkranz RA. Parenteral nutrition-associated cholestasis in small for gestational age infants. J Pediatr 2008; 152:59-62.
7. Hsieh MH, Pai W, Tseng HI, et al. Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors. Pediatr Neonatol 2009; 50:202-207.
8. Quiros-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004; 145:157-163.
9. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000; 24:345-350.
10. Roma MG, Sanchez Pozzi EJ. Oxidative stress: a radical way to stop making bile. Ann Hepatol 2008; 7:1 6-33.
11. Socha P, Koletzko B, Pawlowska J, et al. Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 1997; 24:189-193.
12. Krohn K, Koletzko B. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care 2006; 9:319-323.
13. Gobel Y, Koletzko B, Bohles HJ, et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 2003; 37:161-167.
14. Linseisen J, Hoffmann J, Lienhard S, et al. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr 2000; 19:177-184.
15. Aggett P, Bresson JL, Hernell O, et al. Comment on the vitamin E content in infant formulas, follow-on formulas, and formulas for low birth weight infants. ESPGHAN Committee on Nutrition. European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 1998; 26:351-352.
16. Steger PJ, Muhlebach SF. Lipid peroxidation of intravenous lipid emulsions and all-in-one admixtures in total parenteral nutrition bags: the influence of trace elements. JPEN J Parenter Enteral Nutr 2000; 24:37-41.
17. Sosenko IR, Innis SM, Frank L. Intralipid increases lung polyunsaturated fatty acids and protects newborn rats from oxygen toxicity. Pediatr Res 1991; 30:413-417.
18. Sosenko IR, Innis SM, Frank L. Menhaden fish oil, n-3 polyunsaturated fatty acids, and protection of newborn rats from oxygen toxicity. Pediatr Res 1989; 25:399-404.
19. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis 2007; 27:339-350.
20. Schaeffer L, Gohlke H, Muller M, et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006; 15:1745-1756.
21. Calder PC, Krauss-Etschmann S, de Jong EC, et al. Early nutrition and immunity: progress and perspectives. Br J Nutr 2006; 96:774-790.
22. Forchielli ML, Bersani G, Tala S, et al. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. Lipids 2010; 45: 63-71.
23. Clayton PT, Bowron A, Mills KA, et al. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105:1806-1813.
24. Bindl L, Lutjohann D, Buderus S, et al. High plasma levels of phytosterols in patients on parenteral nutrition: a marker of liver dysfunction. J Pediatr Gastroenterol Nutr 2000; 31:313-316.
25. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998; 14:158-164.
26. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007; 62:301-306.
27. Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr 2008; 27:497-503.
28. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutritionassociated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118:e197-e201.
29. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250:395-402.
30. Ekema G, Falchetti D, Boroni G, et al. Reversal of severe parenteral nutritionassociated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). J Pediatr Surg 2008; 43:1191-1195.
31. Cheung HM, Lam HS, Tam YH, et al. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 2009; 28:209-212.
32. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatricintestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009; 19:348-353. This manuscript reviews the rationale for using parenteral lipid emulsions containing fish oil and the current hypotheses on their benefical effects in PNAC.
33. Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale forthe use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int 2008; 24:773-778.
34. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing fish oil: a single center, double-blind randomized study on long-term efficacy and safety in pediatric patients. J Parenter Enteral Nutr (in press).
35. Tomsits EP, Tolgysi A, Fekete G, Rischaj K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean, olive, coconut and fish oils: a randomized double bling trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr (in press).
36. Mertes N, Grimm H, Furst P, Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006; 50:253-259.
37. Antebi H, Mansoor O, Ferrier C, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J Parenter Enteral Nutr 2004; 28:142-148.
38. Heller AR, Rossel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111:611-616.
39. Piper SN, Schade I, Beschmann RB, et al. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol 2009; 26:1076-1082.
40. Amusquivar E, Ruperez FJ, Barbas C, Herrera E. Low arachidonic acid rather than alpha-tocopherol is responsible for the delayed postnatal development in offspring of rats fed fish oil instead of olive oil during pregnancy and lactation. J Nutr 2000; 130:2855-2865.
41. Carlson SE, Werkman SH, Peeples JM, et al. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993; 90:1073-1077.
42. de Meijer VE, Le HD, Meisel JA, et al. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2009. [Epub ahead of print]